Neuro

CN II

Responsible for assessing vision and visual fields.

Paralysis of CN III

Indicated when a patient is unable to move their eyes upward and inward.

Corneal reflex dysfunction

Partially indicates dysfunction of CN V.

CN I

Responsible for the sense of smell.

CN VII

Involved in facial symmetry and drooping mouth, associated with Bell's palsy.

CN IX

Responsible for tongue and throat function, including swallowing.

Bell's Palsy

Also known as idiopathic facial paralysis.

Acute headache evaluation

Watching for observations indicating serious underlying conditions.

Cluster headache treatment

Best treated with supplemental oxygen.

Migraine with aura

Characterized by unilateral pulsating headaches with visual disturbances.

Tension-type headache pain

Typically described as 'pressing' in quality.

Corticosteroid therapy in Bell's palsy

Should be initiated as soon as possible after paralysis onset.

Antivirals for Bell's palsy

Considered but not proven beneficial in studies.

Corticosteroid side effects

High rate of rebound headache if used frequently.

Diagnosis of PD

Relies on clinical evaluation of cardinal features such as tremor at rest and bradykinesia.

Kernig sign

Indicates meningitis; resistance or pain occurs with extension of the knee when hip is flexed.

Factors influencing stroke risk

Include hypertension, dyslipidemia, and smoking.

Meningococcal meningitis transmission risk

Individuals with household-type contact are at risk.

Neuroleptics usage limit

Limit to less than three times per week due to EPM risk.

MS causes

Described as a destructive process of the nerve fiber protecting myelin.

Migraine prevention supplements

Evidence supports use of vitamins except ginkgo biloba.

Acute cerebral hemorrhage diagnosis

Best identified with CT scan.

DOAC secondary prevention

Useful for ischemic stroke with cardioembolic conditions.

GCA symptoms

Unilateral throbbing headache with temporal artery involvement.

Blindness complication

Serious risk associated with GCA.